Copenhagen, Denmark – February 20, 2018: Mads Andersen, founder and Chief Scientific Officer at IO Biotech, has published an article in Cancer Research relating to the company’s clinical stage technology.
New article published in Cancer Research: “The Balance Players of the Adaptive Immune System“
Other news